Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lakefront Biotherapeutics West Llc

Clinical trials sponsored by Lakefront Biotherapeutics West Llc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug OM336 aims to tame overactive immune system Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New drug OM336 aims to tame overactive immune system

Disease control Recruiting now

This early-phase trial tests a new drug called OM336 in 32 adults with autoimmune cytopenias, conditions where the immune system attacks blood cells. The study focuses on safety and how the drug moves through the body, not yet on curing the disease. Participants must have tried a…

Phase 1 • Sponsor: Lakefront Biotherapeutics West LLC • Aim: Disease control

Last updated Sep 05, 2026 00:00 UTC